211 related articles for article (PubMed ID: 6140616)
41. Ulcer disease of the upper gastrointestinal tract.
Meeroff JC
Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
[No Abstract] [Full Text] [Related]
42. Cimetidine and ulcers.
Br Med J; 1976 Nov; 2(6047):1275-6. PubMed ID: 11866
[No Abstract] [Full Text] [Related]
43. Treatment of duodenal ulcer.
Eliakim R; Rachmilewitz D
Rev Clin Basic Pharm; 1985; 5(3-4):215-33. PubMed ID: 2881325
[TBL] [Abstract][Full Text] [Related]
44. Ranitidine.
Strum WB
JAMA; 1983 Oct; 250(14):1894-6. PubMed ID: 6312110
[TBL] [Abstract][Full Text] [Related]
45. [Surgical treatment of gastroduodenal ulcer disease. Our experience after the advent of H2-antagonist drugs].
Carrella G; Salomoni C; De Anna D; Pozza E; Sortini A; Guerrera C; Pansini GC; Marcello D; Vettorello GF
Minerva Chir; 1987 Oct; 42(19):1483-5. PubMed ID: 2891084
[No Abstract] [Full Text] [Related]
46. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
[TBL] [Abstract][Full Text] [Related]
47. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
Tomasko MA; Luskin AT
Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
[No Abstract] [Full Text] [Related]
48. [Further development of the H2-blocker in ulcer therapy].
Domschke S; Domschke W
Med Klin; 1981 Jan; 76(3):68-73. PubMed ID: 6111744
[No Abstract] [Full Text] [Related]
49. [Treatment of duodenal ulcer with histamine H2 antagonists and alkalies].
Russu G; Alucăi V
Rev Med Chir Soc Med Nat Iasi; 1986; 90(2):243-7. PubMed ID: 2876471
[No Abstract] [Full Text] [Related]
50. New horizons in the pharmacologic management of peptic ulceration.
Debas HT; Mulholland MW
Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
[TBL] [Abstract][Full Text] [Related]
51. [Comparison of famotidine and ranitidine in duodenal ulcer].
Rohner HG; Gugler R; Kimmig JM; Schönekäs H
Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
[No Abstract] [Full Text] [Related]
52. [New developments in drug therapy: omeprazole].
Koop H
Z Gastroenterol Verh; 1991 Mar; 26():159-61. PubMed ID: 1714134
[No Abstract] [Full Text] [Related]
53. Duodenal ulcers that are difficult to heal.
Pounder R
BMJ; 1988 Dec; 297(6663):1560-1. PubMed ID: 2906259
[No Abstract] [Full Text] [Related]
54. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice].
Rimassa PL; Marino G; Quartapelle V; D'Asta F; Maggiolo G; Manno A; Piffero D; Schiappacasse E
Minerva Chir; 1987 Oct; 42(19):1499-502. PubMed ID: 2891087
[No Abstract] [Full Text] [Related]
55. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
56. [New antisecretory drugs in the treatment of ulcer].
Sheptulin AA
Klin Med (Mosk); 1994; 72(1):12-5. PubMed ID: 7910870
[No Abstract] [Full Text] [Related]
57. [Famotidine (quamatel) for treatment of ulcer disease].
Bogachev RS; Levina ZK
Khirurgiia (Mosk); 1999; (1):34. PubMed ID: 10050509
[No Abstract] [Full Text] [Related]
58. [Multi-center double-blind clinical trial of ranitidine in the treatment of stomach and duodenal ulcers].
Gibiński K; Nowak A; Gabrylewicz A; Laszewicz W; Hasik J; Klincewicz H; Pokora J; Czarnecki J; Kosecki J; Pachlewski J
Pol Arch Med Wewn; 1982; 68(3):117-24. PubMed ID: 6133269
[No Abstract] [Full Text] [Related]
59. [Treatment of gastric and duodenal ulcer].
Berndt H
Z Arztl Fortbild (Jena); 1986; 80(2):45-6. PubMed ID: 3962348
[No Abstract] [Full Text] [Related]
60. Peptic ulcer in the Royal Navy.
Hunt RH
J R Nav Med Serv; 1981; 67(3):125-30. PubMed ID: 6121054
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
